Cargando…
Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements
Cardiovascular diseases (CVD) continue to be the leading cause of morbidity and mortality globally and claim the lives of over 17 million people annually. Current management of CVD includes risk factor modification and preventative strategies including dietary and lifestyle changes, smoking cessatio...
Autores principales: | Huerta, Carlos Theodore, Voza, Francesca A., Ortiz, Yulexi Y., Liu, Zhao-Jun, Velazquez, Omaida C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436297/ https://www.ncbi.nlm.nih.gov/pubmed/37600026 http://dx.doi.org/10.3389/fcvm.2023.1236345 |
Ejemplares similares
-
Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: A review of preclinical and clinical studies
por: Huerta, Carlos Theodore, et al.
Publicado: (2023) -
Novel Gene-Modified Mesenchymal Stem Cell Therapy Reverses Impaired Wound Healing in Ischemic Limbs
por: Huerta, Carlos Theodore, et al.
Publicado: (2023) -
E-Selectin-Overexpressing Mesenchymal Stem Cell Therapy Confers Improved Reperfusion, Repair, and Regeneration in a Murine Critical Limb Ischemia Model
por: Quiroz, Hallie J., et al.
Publicado: (2022) -
E-Selectin/AAV2/2 Gene Therapy Alters Angiogenesis and Inflammatory Gene Profiles in Mouse Gangrene Model
por: Ribieras, Antoine J., et al.
Publicado: (2022) -
E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model
por: Ribieras, Antoine J., et al.
Publicado: (2023)